Net income (loss) per share of Ordinary shares (Tables)

3 Months Ended

Sep. 30, 2026

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table presents potentially dilutive securities that were not included in the computation of diluted net income (loss) per share of Ordinary shares as their inclusion would have been anti-dilutive:


	Three Months Ended September 30,
	2026	2025
Stock options	5,050,763	4,832,406
Restricted stock units	31,720,097	67,070
Investment Rights	30,000,000	—
Convertible notes	127,225,107	—
Total	193,995,967	4,899,476

Schedule of Reconciliation of the Denominator of the Basic and Diluted Net Income (Loss) Per Share

The following is a reconciliation of the numerator and denominator of the basic and diluted net income (loss) per share of Ordinary shares for the periods presented:


(in USD millions, except share and per share amounts)	Three Months Ended September 30,
	2026		2025
Numerator:
Net income (loss)	$	(263)	$	385
Convertible notes interest expense, net of tax	—		7
Numerator for diluted net income (loss) per share of Ordinary shares	$	(263)	$	392

Denominator:
Basic weighted-average shares used in computing net income (loss) per share of Ordinary shares	398,557,846		270,696,733
Effects of dilutive securities:
Options	—		2,088,098
Restricted stock units	—		22,387,881
Convertible notes	—		66,507,881
Dilutive potential Ordinary shares	—		90,983,860
Diluted weighted-average shares used in computing net income (loss) per share of Ordinary shares	398,557,846		361,680,593

Basic net income (loss) per share of Ordinary shares	$	(0.66)	$	1.42
Diluted net income (loss) per share of Ordinary shares	$	(0.66)	$	1.08